Related Experiment Video
Updated: Aug 10, 2026

Mouse Models for Graft Arteriosclerosis
Published on: May 14, 2013
Cardiac allograft rejection late after transplantation is a risk factor for graft coronary artery disease
H P Brunner-La Rocca1, J Schneider, A Künzli
1Division of Cardiology, University Hospital Zurich, Switzerland.
Insights
Cellular rejection episodes requiring increased immunosuppression, both early and late after heart transplantation, significantly increase the risk of developing graft coronary artery disease (CAD). Aggressively treating rejection is crucial for long-term graft survival.
Area of Science:
- Cardiology
- Immunology
- Transplantation Medicine
Background:
- Graft coronary artery disease (CAD) is a significant concern in long-term heart transplant recipients.
- The role of cellular rejection, especially late after transplantation, in graft CAD development is not fully understood.
Purpose of the Study:
- To investigate the association between cellular rejection and the development of angiographically detectable graft CAD in heart transplant recipients.
- To identify independent predictors of graft CAD in this population.
Main Methods:
- Analysis of 492 coronary angiographies and 5201 endomyocardial biopsies from 156 heart transplant patients.
- Multivariate logistic regression analysis incorporating rejection episodes, cytomegalovirus infection, donor age, and smoking status.
Main Results:
- Patients with graft CAD experienced significantly more rejection episodes than those without, both early and late post-transplant.
- Number of rejections (early and late), prior cytomegalovirus infection, older donor age, and smoker status were independent predictors of graft CAD.
- Late rejection episodes strongly predicted graft CAD, even in patients without detectable disease at one year.
Conclusions:
- Rejection episodes requiring augmented immunosuppression, occurring both early and late post-transplant, are independent risk factors for graft CAD.
- Proactive identification and management of moderate to severe rejection are recommended, even in the late stages after heart transplantation.
Background:
Graft coronary artery disease (CAD) is an increasingly important problem during long-term survival after heart transplantation, but the importance of cellular rejection, in particular late after transplantation, remains undetermined.
Methods And Results:
We analyzed 492 coronary angiographies (967+/-705 days after transplantation; range, 49 days to 9.4 years) and 5201 endomyocardial biopsies (518+/-648 days after transplantation) from 156 patients (age, 47+/-11 years). Patients with angiographically detectable graft CAD had significantly more episodes of rejection requiring augmentation of immunosuppressive therapy (i.e., International Society of Heart and Lung Transplantation score > or = 3A) than those without graft CAD during the first (3.7+/-2.6 vs. 2.2+/-2.0, P<0.001) as well as subsequent years after transplantation (1.2+/-1.9 vs. 0.4+/-0.9, P<0.01). Multivariate logistic regression analysis including established risk factors for CAD, ischemic time, gender and age of donors and recipients, number of mismatches, cytomegalovirus infection, and drug therapy showed that the number of rejections during the first [odds ratio (OR)=1.39, P<0.005] as well as subsequent years (OR=1.49, P<0.05), previous cytomegalovirus infection (OR=3.21, P<0.05), donor age >40 years (OR=2.97, P<0.05), and current or former smoker status (OR=2.76, P<0.05) were independent predictors of graft CAD. In patients without angiographically detectable graft CAD 1 year after transplantation, the number of rejections after the first year was even more strongly related to graft coronary artery disease than in the total patient population, underlining the importance of late cellular rejection (OR=1.74, P<0.005).
Conclusion:
Rejection requiring augmentation of immunosuppression early and late after transplantation is an independent risk factor for the development of angiographically detectable graft CAD. Hence, the search for and treatment of moderate or severe rejection seems to be prudent even late after transplantation.
Related Concept Videos
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure

